Back
Black Diamond Therapeutics Stock Price Chart
Sponsored
BDTX
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
BDTX
Black Diamond Therapeutics
Last Price:
2.42
Seasonality Move:
21.01%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDTX is experiencing slight selling pressure.
Black Diamond Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.84 | Sell |
20-day SMA: | 2.95 | Sell |
50-day SMA: | 3.68 | Sell |
200-day SMA: | 4.87 | Sell |
8-day EMA: | 2.73 | Sell |
20-day EMA: | 2.99 | Sell |
50-day EMA: | 3.6 | Sell |
200-day EMA: | 4.32 | Sell |
Black Diamond Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.28 | Sell |
Relative Strength Index (14 RSI): | 29.57 | Sell |
Chaikin Money Flow: | -208420 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.73 - 3.29) | Sell |
Bollinger Bands (100): | (3.41 - 5.87) | Sell |
Black Diamond Therapeutics Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Black Diamond Therapeutics Stock
Is Black Diamond Therapeutics Stock a Buy?
- Black Diamond Therapeutics share price is 2.43 while BDTX 8-day simple moving average is 2.84, which is a Sell signal.
- The stock price of BDTX is 2.43 while Black Diamond Therapeutics 20-day SMA is 2.95, which makes it a Sell.
- Black Diamond Therapeutics 50-day simple moving average is 3.68 while BDTX share price is 2.43, making it a Sell technically.
- BDTX stock price is 2.43 and Black Diamond Therapeutics 200-day simple moving average is 4.87, creating a Sell signal.
BDTX Technical Analysis vs Fundamental Analysis
Sell
34
Black Diamond Therapeutics (BDTX)
is a Sell
Is Black Diamond Therapeutics a Buy or a Sell?
-
Black Diamond Therapeutics stock is rated a Sell
The current Black Diamond Therapeutics [BDTX] share price is $2.43. The Score for BDTX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Black Diamond Therapeutics Stock Info
Market Cap:
137.5M
Price in USD:
2.43
Share Volume:
468.95K
Black Diamond Therapeutics 52-Week Range
52-Week High:
7.66
52-Week Low:
2.12
Sell
34
Black Diamond Therapeutics (BDTX)
is a Sell
Black Diamond Therapeutics Share Price Forecast
-
What is the Black Diamond Therapeutics stock price today?
The Black Diamond Therapeutics stock price is 2.43 USD today. -
Will BDTX stock go up or go down?
Black Diamond Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Black Diamond Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Black Diamond Therapeutics is overvalued.
Is Black Diamond Therapeutics Stock a Buy?
- Black Diamond Therapeutics share price is 2.43 while BDTX 8-day exponential moving average is 2.73, which is a Sell signal.
- The stock price of BDTX is 2.43 while Black Diamond Therapeutics 20-day EMA is 2.99, which makes it a Sell.
- Black Diamond Therapeutics 50-day exponential moving average is 3.60 while BDTX share price is 2.43, making it a Sell technically.
- BDTX stock price is 2.43 and Black Diamond Therapeutics 200-day simple moving average is 4.32, creating a Sell signal.
Fundamental Analysis of Black Diamond Therapeutics
Is Black Diamond Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $0.02 per share.
Technical Analysis of Black Diamond Therapeutics
Should I short Black Diamond Therapeutics stock?
- BDTX Moving Average Covergence Divergence (MACD) indicator is -0.28, suggesting Black Diamond Therapeutics is a Sell
- Black Diamond Therapeutics Relative Strength Index (RSI) is 29.57, which suggest Black Diamond Therapeutics is oversold
- The Bollinger Bands (25) for Black Diamond Therapeutics is (2.73 - 3.29), which suggest Black Diamond Therapeutics is a Sell
- The Bollinger Bands (100) for Black Diamond Therapeutics is (3.41 - 5.87), which suggest Black Diamond Therapeutics is a Sell
* Black Diamond Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.